fda glp-1 compounding warning october 2025 National Hispanic Medical Association | After compounded drugs were banned, counterfeit versions continued to circulate — and still do today. Understanding the risks and As GLP-1 weight-loss drugs surged

Kadowaki T, Kiyosue A, Shingaki T, Oura T, Yokote K

Barrington P, Chien JY, Showalter HD et al (2011) A 5-week study of the pharmacokinetics and pharmacodynamics of LY2189265, a novel, long-acting glucagon-like peptide-1 analogue, in patients with type 2 diabetes

In this study, the greater treatment persistence and comparable adherence of semaglutide QW versus these other GLP-1 RAs may be a result of the associated clinical benefits of semaglutide QW such as improved glycemic control and greater weight loss [21, 25]

W., and Roberts, M

Clinical evidence shows that semaglutide and other GLP-1 agonists do not directly suppress testosterone production